Skip to main content

Smith & Nephew Snats ADR(SNN-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Smith+Nephew expands procedural innovation with introduction of JOURNEY™ II ROX™ Total Knee Solution

PR Newswire - Tue Nov 1, 2022

LONDON, Nov. 1, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of its JOURNEY II ROX Total Knee Solution – a reverse hybrid construct for total knee arthroplasty. This new procedural product solution aims to provide surgeons with the clinical advantage of an advanced bearing material and anatomic design combined with the efficiency1 and potential long-term tibia fixation of a cementless knee.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe